RBC Capital analyst Mark Dwelle downgrades Ryan Specialty Holdings (NYSE:RYAN) from Outperform to Sector Perform.
What 10 Analyst Ratings Have To Say About Mirati Therapeutics
Over the past 3 months, 10 analysts have published their opinion on Mirati Therapeutics (NASDAQ:MRTX) stock. These analysts…